Effects of the once-daily GLP-1 analog liraglutide on gastric emptying, glycemic parameters, appetite and energy metabolism in obese, non-diabetic adults-Reference-Cited by-同舟云学术

Effects of the once-daily GLP-1 analog liraglutide on gastric emptying, glycemic parameters, appetite and energy metabolism in obese, non-diabetic adults

Published:2013-09-03 Issue:6 Volume:38 Page:784-793
ISSN:0307-0565
Container-title:International Journal of Obesity
language:en
Short-container-title:Int J Obes

Author:

van Can J,Sloth B,Jensen C B,Flint A,Blaak E E,Saris W H M

Publisher

Springer Science and Business Media LLC

Subject

Nutrition and Dietetics,Endocrinology, Diabetes and Metabolism,Medicine (miscellaneous)

Link

http://www.nature.com/articles/ijo2013162.pdf

Reference40 articles.

1. Kopelman PG . Obesity as a medical problem. Nature 2000; 404: 635–643.

2. Mokdad AH, Ford ES, Bowman BA, Dietz WH, Vinicor F, Bales VS et al. Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001. JAMA 2003; 289: 76–79.

3. Bays HE . Current and investigational antiobesity agents and obesity therapeutic treatment targets. Obes Res 2004; 12: 1197–1211.

4. Meier JJ, Gethmann A, Gotze O, Gallwitz B, Holst JJ, Schmidt WE et al. Glucagon-like peptide 1 abolishes the postprandial rise in triglyceride concentrations and lowers levels of non-esterified fatty acids in humans. Diabetologia 2006; 49: 452–458.

5. Wettergren A, Schjoldager B, Mortensen PE, Myhre J, Christiansen J, Holst JJ . Truncated GLP-1 (proglucagon 78-107-amide) inhibits gastric and pancreatic functions in man. Dig Dis Sci 1993; 38: 665–673.

Cited by 366 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Confounding Factors in the Association Between Glucagon-Like Peptide-1 Receptor Agonist Use and Retained Gastric Contents in Asymptomatic Patients Undergoing Upper Gastrointestinal Endoscopy: A Retrospective Study;Cureus;2024-09-11

2. Liraglutide for Children 6 to <12 Years of Age with Obesity — A Randomized Trial;New England Journal of Medicine;2024-09-10

3. Modern Challenges in Type 2 Diabetes: Balancing New Medications with Multifactorial Care;Biomedicines;2024-09-07

4. GLP-1R–positive neurons in the lateral septum mediate the anorectic and weight-lowering effects of liraglutide in mice;Journal of Clinical Investigation;2024-09-03

5. Glucagon-like peptide 1 agonist and effects on reward behaviour: A systematic review;Physiology & Behavior;2024-09